HERizon-Breast: A ctDNA-Guided Adaptive Study of Sequential Anti-HER2 Therapies and CNS Prophylaxis to Induce Long-Term Remission
Clinical trial NCT07459673 · RECRUITING
Trial details
- NCT number
- NCT07459673
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-04
- Primary completion
- 2030-03-04
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.